Tag Archives: Drug

PBM Startup Capital Rx Starts Prescription Drug Pricing Shake-Up with Walmart Partnership

Health Tech Jul 30, 2020• By JESSICA DaMASSA, WTF HEALTH A startup PBM? Partnered up with Walmart to bring “everyday low prices” to prescription drug pricing? Is this too good to be true? A.J. Loiacono, founder & CEO at Capital Rx, gives us a quick primer on “Pharmacy Benefit Managers” (PBMs) and why they’ve become… Read More »

Tremfya (guselkumab) Approved by U.S. Food and Drug Administration as the First Selective Interleukin (IL)-23 Inhibitor for Active Psoriatic Arthritis

Print this page HORSHAM, PA, July 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.[1],[2] Tremfya is the first treatment… Read More »

Therapeutic Drug Monitoring

What do the results mean? Your results will show if medicine levels in your blood are in a range that is medically helpful but not dangerous. This is called the therapeutic range. The range varies depending on the type of medicine and your own health needs. If your results are not in this range, your… Read More »

U.S. FDA approves GSK unit’s drug to treat infants and children with HIV

FILE PHOTO: A GSK logo is seen on a flag at a GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls/File Photo (Reuters) – The U.S. Food and Drug Administration has approved a drug to treat infants and children with HIV, with the drug having been developed by drugmaker GlaxoSmithKline’s HIV drugs… Read More »